Medical food designs to enhance GLP-1 secretion in drug therapy
Innovative oral delivery system providing sustained release of incretin-stimulating postbiotic SCFAs, enhancing GLP-1 levels to support T2 diabetes control and weight loss. Aims to match the efficacy of gastric surgeries...